About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cebpatm1Dgt
targeted mutation 1, Daniel G Tenen
MGI:3522010
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cebpatm1Dgt/Cebpatm1Dgt involves: 129S6/SvEvTac MGI:3525183
cn2
Cebpatm1Dgt/Cebpatm1Dgt
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
involves: 129 * 129S6/SvEvTac * C57BL/6 MGI:4942158
cn3
Cebpatm1Dgt/Cebpatm1Dgt
Tg(Mx1-cre)1Cgn/0
involves: 129S6/SvEvTac * C57BL/6 * CBA MGI:3525184


Genotype
MGI:3525183
hm1
Allelic
Composition
Cebpatm1Dgt/Cebpatm1Dgt
Genetic
Background
involves: 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cebpatm1Dgt mutation (2 available); any Cebpa mutation (16 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no notable abnormalities in the hematopoietic system were detected




Genotype
MGI:4942158
cn2
Allelic
Composition
Cebpatm1Dgt/Cebpatm1Dgt
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
Genetic
Background
involves: 129 * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cebpatm1Dgt mutation (2 available); any Cebpa mutation (16 available)
Tg(SFTPC-rtTA)5Jaw mutation (4 available)
Tg(tetO-cre)1Jaw mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• although born in Mendelian ratios, most mice exposed to doxycycline from conception die of respiratory failure at birth

respiratory system
• doxycycline-exposed newborn mice show a reduction of airspace, sometimes obliterating the alveolar structure
• in addition, neonatal alveolar cells show significantly decreased numbers of TUNEL-positive cells, indicating reduced apoptosis
• doxycycline-exposed newborn mice display increased numbers of Ki-67-positive alveolar cells, indicating increased alveolar cell proliferation
• doxycycline-exposed newborn mice lack type I alveolar cells
• alveoli of doxycycline-exposed newborn mice are lined by immature cuboidal type II cells with a clear cytosol, round nuclei and high glycogen content, indicating a type II cell differentiation arrest
• immature type II alveolar cells of doxycycline-exposed newborn mice lack lamellar bodies
• doxycycline-exposed newborn mice lack mature type II alveolar cells
• doxycycline-exposed newborn mice display thicker alveolar walls due to marked cellular accumulation
• 86% of mice exposed to doxycycline from conception show signs of respiratory distress within hours after birth
• most mice exposed to doxycycline from conception to birth display respiratory failure
• doxycycline-exposed newborn mice show a marked loss of surfactant protein B (SP-B) by immunostaining
• mRNAs for SP-A and SP-D are significantly down-regulated

liver/biliary system
N
• doxycycline-exposed mice have a normal liver architecture and show normal Cebpa mRNA levels in liver

hematopoietic system
N
• doxycycline-exposed mice exhibit normal granulocytic differentiation in fetal liver and contain granulocytes in peripheral blood




Genotype
MGI:3525184
cn3
Allelic
Composition
Cebpatm1Dgt/Cebpatm1Dgt
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cebpatm1Dgt mutation (2 available); any Cebpa mutation (16 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants treated with poly I:C rarely survive beyond 4-5 weeks of age due to granulocytopenia and sepsis

hematopoietic system
• a dramatic loss of Gr-1+ Mac-1+ neutrophils/monocytes is seen in the bone marrow, spleen, and peripheral blood, however T and B cell numbers are normal
• after poly I:C treatment myelocytes, neutrophils, monocytes, and eosinophils are rarely seen in the bone marrow and the number of immature myeloblasts is increased 32%
• in vitro common myeloid progenitor cells fail to form any mature granulocyte-macrophage, macrophage, or granulocytic colonies
• injection of poly I:C at 2 days after birth resulted in absence of mature granulocytes, however mutants do not develop anemia, thrombocytopenia, or leukemia

immune system
• a dramatic loss of Gr-1+ Mac-1+ neutrophils/monocytes is seen in the bone marrow, spleen, and peripheral blood, however T and B cell numbers are normal
• after poly I:C treatment myelocytes, neutrophils, monocytes, and eosinophils are rarely seen in the bone marrow and the number of immature myeloblasts is increased 32%
• in vitro common myeloid progenitor cells fail to form any mature granulocyte-macrophage, macrophage, or granulocytic colonies
• injection of poly I:C at 2 days after birth resulted in absence of mature granulocytes, however mutants do not develop anemia, thrombocytopenia, or leukemia





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory